Clinical Trial Update: SPHERE Per-AF Post-Approval Study

View source ↗

Summary

The SPHERE Per-AF post-approval study by Medtronic Cardiac Ablation Solutions is currently recruiting patients with persistent atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• SPHERE Per-AF

Snippet

Sponsor: Medtronic Cardiac Ablation Solutions | Conditions: Persistent Atrial Fibrillation | Status: RECRUITING